Johnson and Johnson discontinued the sale of its talcum baby powder in USA, Canada

There have been claims for the products of Johnson and Johnson to lead to cancer. They lost millions of dollars due to this and now are planning on shutting the sales of talcum based baby powder in the united states. The company denied all the allegations.

- Advertisement -

“Demand for talc-based Johnson’s powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a continuing barrage of litigation advertising,” Johnson & Johnson said.

“From a minimum of 1971 to the first 2000s, the company’s raw talc and finished powders sometimes tested positive for little amounts of asbestos, which company executives, mine managers, scientists, doctors and lawyers fretted over the matter and the way to deal with it while failing to disclose it to regulators or the general public,” came into the scene Reuters and therefore the New York Times in December 2018 showed some documents over this. However, the company denied the news.

In 2018, a St. Louis jury ordered Johnson & Johnson to pay $4.7 billion to 22 women and their families who claimed to their ovarian cancer. Last year, a woman in California said that caused her to develop mesothelioma was awarded $29 million.

- Advertisement -
- Advertisement -

Latest article